Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Access program - sildenafil citrate, viagra, revatio
(D02229)		----1件: 86 💬
2DUO-therapy with sildenafil + bosentan
(D02229)		----1件: 86 💬
3MONO-therapy with sildenafil
(D02229)		----1件: 86 💬
4Oral sildenafil
(D02229)		----1件: 86 💬
5Sildenafil
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬14件: 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
6Sildenafil (revatio) 20 MG TID
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
7Sildenafil 20 MG tablets
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 278 💬
8Sildenafil 20MG and bosentan 62.5MG
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
9Sildenafil 40MG oral capsule
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299 💬
10Sildenafil and losartan
(D02229)		2件: Losartan,
Sildenafil		4件: Losartan potassium ,
Sildenafil citrate (D02229),
Losartan ,
Sildenafil 💬 		2件: AGTR1,
PDE5 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 85 💬
11Sildenafil BY injection
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 210 💬
12Sildenafil citrate
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬4件: 51, 85, 86, 225 💬
13Sildenafil filmtabletten
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
14Sildenafil oral suspension
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294 💬
15Sildenafil singly or IN association with bosentan
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
16Sildenafil therapy
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 51 💬
17Sitaxsentan and sildenafil
(D02229)		1件: Sitaxentan2件: Sitaxentan ,
Sitaxentan sodium 💬 		1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
18Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20MG sildenafil citrate BY mouth
(D02229)		1件: Sildenafil2件: Sildenafil citrate (D02229),
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
19Tadalafil and sildenafil
(D02229)		1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113 💬